Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Vision Group Holdings filed for bankruptcy first — could more be next? Insights from Provident experts

Skip to the end of the Expertise Menu
West Palm Beach, Fla.-based and private equity-backed Vision Group Holdings said the COVID-19 pandemic worsened its financial issues when it filed for Chapter 11 bankruptcy at the beginning of June. As the ramifications of the virus continue to make themselves known, will this be a one-time occurrence or the beginning of a chain of similar filings?


Provident Healthcare Partners Director Eric Major and Associate Steven Grassa discussed the filing with Becker’s and predicted how ophthalmology-based investments were going to be hit by COVID-19.

While Chapter 11 bankruptcy is a common occurrence in the world of business, specifically in retail, it’s not as common in healthcare, because practices are more recession-proof than more cyclical businesses, Mr. Major said.

Vision Group Holdings and its associated brands, Laser Vision Institute and TLC Laser Eye Centers, focus primarily on performing Lasik eye surgery. In the pandemic-recessed economy, the financials around elective Lasik surgery aren’t as promising as a general ophthalmology practice.

To access the full article, click on the following link: Vision Group Holdings filed for bankruptcy first — could more be next? Insights from Provident experts

About Becker’s ASC Review
Becker’s ASC Review features general business, legal and clinical guidance on topics relevant to outpatient surgery including joint-ventures, development and expansion, and regulatory and compliance issues; as well as analysis and insight for specialties including bariatrics, orthopedics and spine, gastroenterology, neurosurgery, ophthalmology, ENT and anesthesiology. Each of the nine annual issues of the publication reaches a qualified audience of more than 25,000 key ASC leaders, including surgeons, medical directors, directors of surgery and ASC administrators. Further, every ASC in the nation receives Becker’s ASC Review. Visit Becker’s ASC Review at